Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Quest Diagnostics Incorporated DGX

Healthcare  —  Diagnostics & Research
236.32 (0.27) (0.11%) as of 25 Sep
Market cap
$26.2B
P/E
24.8×
S&P 500 Member Dividend Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio 19.56 19.39 18.55 19.33 10.90 11.24 16.79 15.45 17.57 20.23
P/S ratio 1.75 1.70 1.70 1.83 2.00 1.69 1.85 1.50 1.83 1.79
P/FCF ratio 14.17 18.42 18.25 13.75 11.82 10.06 16.97 13.86 14.68 15.73
P/Operating CF 41.42 36.09 29.93 54.10 44.96 29.52 41.12 38.39 41.95 36.87
P/B ratio 2.67 2.46 2.49 3.05 3.34 2.35 2.52 2.15 2.73 2.78
Price to Tangible BV 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales 2.22 2.27 2.14 2.20 2.30 1.99 2.32 2.00 2.32 2.26
EV/EBITDA 11.53 12.19 11.64 11.65 8.88 8.07 11.47 10.70 11.98 10.69
EV/Operating CF 13.00 16.80 15.57 12.65 11.09 9.39 14.39 12.57 14.64 14.62
EV/FCF 18.04 24.66 22.92 16.54 13.53 11.86 21.22 18.46 18.63 19.83
Quick Ratio 0.80 0.85 1.04 0.97 1.32 1.51 1.13 0.77 1.00 1.31
Current Ratio 1.04 1.10 1.31 1.22 1.56 1.72 1.25 0.94 1.24 1.56
Net Debt/EBITDA 2.47 3.08 2.37 1.97 1.13 1.23 2.29 2.67 2.54 2.21
Debt/Assets 34.95% 38.49% 33.61% 31.00% 29.48% 28.63% 37.14% 35.38% 36.03% 36.97%
Debt/Equity 0.79 0.91 0.74 0.67 0.62 0.59 0.84 0.74 0.76 0.80
Asset Turnover 0.68 0.65 0.69 0.75 0.78 0.70 0.65 0.70 0.72 0.72
Operating CF/Net income 1.91 1.54 1.50 1.82 1.12 1.41 1.45 1.63 1.52 1.74
Capex/Depreciation (0.92) (0.86) (0.93) (0.92) (0.99) (1.16) (1.22) (1.24) (0.93) (1.18)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 14.10% 13.17% 13.85% 15.18% 29.91% 22.81% 15.67% 14.40% 16.06% 13.70%
ROA 6.10% 5.74% 6.33% 7.12% 14.39% 10.61% 7.20% 6.84% 7.49% 6.40%
ROIC 7.81% 6.74% 7.61% 9.30% 15.46% 12.74% 8.30% 7.62% 8.46% 9.93%
Return on Tangible Assets 42.90% 37.07% 35.82% 44.58% 73.77% 48.99% 43.93% 61.69% 55.38% 40.66%
Average Days of Receivables 46.57 48.21 47.74 44.13 48.65 58.79 50.22 49.05 45.56 46.85
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 17.83% 17.93% 17.75% 18.96% 16.01% 16.42% 18.86% 18.91% 19.49% 19.13%
Intangible Assets out of Total Assets 0.65 0.66 0.63 0.65 0.61 0.57 0.60 0.71 0.71 0.69
Share Based Compensation of Revenue 0.80% 0.89% 0.83% 0.78% 0.73% 1.03% 0.72% 0.81% 1.07% 0.96%
Graham Net Nets (0.34) (0.41) (0.34) (0.28) (0.20) (0.26) (0.33) (0.38) (0.31) (0.30)
Graham Number 113.83 103.65 98.34 96.28 136.09 110.09 77.93 68.53 67.69 58.50
Earnings Yield 5.11% 5.16% 5.39% 5.17% 9.17% 8.89% 5.96% 6.47% 5.69% 4.94%
Free Cash Flow Yield 7.06% 5.43% 5.48% 7.27% 8.46% 9.94% 5.89% 7.21% 6.81% 6.36%
Revenue per Share 99.41 88.94 82.61 85.20 86.30 70.43 57.66 55.38 54.03 51.53
Operating CF per Share 16.99 12.02 11.36 14.81 17.86 14.96 9.28 8.82 8.58 7.97
Capex per Share (4.75) (3.83) (3.64) (3.48) (3.22) (3.12) (2.99) (2.82) (1.84) (2.09)
Free Cash Flow per Share 12.24 8.19 7.71 11.33 14.64 11.84 6.29 6.01 6.74 5.88
Cash per Share 3.78 4.95 6.13 2.72 6.98 8.64 8.90 0.99 1.00 2.56
Shareholders Equity per Share 64.92 61.38 56.63 51.12 51.86 50.81 42.44 38.73 36.17 33.29
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 64.92 61.38 56.63 51.12 51.86 50.81 42.44 38.73 36.17 33.29
Free Cash Flow 1,359.00 909.00 864.00 1,314.00 1,830.00 1,587.00 843.00 817.00 923.00 823.00
Working Capital 100.00 223.00 557.00 347.00 988.00 1,282.00 500.00 (95.00) 249.00 550.00
Capital Expenditures (527.00) (425.00) (408.00) (404.00) (403.00) (418.00) (400.00) (383.00) (252.00) (293.00)
Net Current Asset Value (6,641.00) (6,948.00) (5,308.00) (5,009.00) (4,387.00) (4,159.00) (4,666.00) (4,346.00) (4,242.00) (3,909.00)
EV/EBIT 15.75 16.65 15.69 15.22 10.40 9.55 14.53 13.70 14.76 12.78
Capex to Sales 0.05 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.03 0.04
Net Profit Margin 8.95% 8.77% 9.19% 9.53% 18.43% 15.10% 11.11% 9.77% 10.43% 8.90%
Price to Operating Income 12.38 12.44 12.50 12.65 9.08 8.10 11.62 10.29 11.63 10.14
Other line items
Depreciation/Fixed assets 0.26 0.23 0.24 0.25 0.24 0.22 0.23 0.24 0.24 0.24
Cash ROIC (2.38%) (5.74%) (4.63%) (0.47%) 4.63% 3.15% (1.80%) (0.95%) 0.34% 0.99%
Accounts Receivable Turnover 8.14 7.85 7.69 7.51 7.29 7.31 7.45 7.78 8.00 7.90
Accounts Payable Turnover 4.92 4.82 4.50 4.31 4.07 4.34 4.89 4.82 4.73 4.64
Inventory Turnover 39.10 35.07 32.46 32.25 30.53 33.55 45.38 50.78 53.32 55.61
Average Days of Payables 79.24 76.77 80.02 79.00 88.77 102.70 75.43 75.65 78.97 77.10
Days of Inventory on Hand 9.36 10.35 11.19 10.87 11.54 14.02 8.91 7.34 7.35 6.48
Average Receivables 1,356.00 1,257.00 1,202.50 1,316.50 1,479.00 1,291.50 1,037.50 968.00 925.00 913.50
Average Payables 1,497.00 1,376.50 1,377.50 1,498.00 1,616.50 1,337.00 1,031.00 1,021.00 998.00 994.50
Average Inventory 188.50 189.00 191.00 200.00 215.50 173.00 111.00 97.00 88.50 83.00
Average Assets 16,189.00 15,087.50 13,429.50 13,224.00 13,818.50 13,434.50 11,923.00 10,753.00 10,301.50 10,031.00
Average Common Equity 7,009.50 6,577.50 6,136.00 6,206.50 6,646.00 6,248.00 5,477.00 5,111.00 4,807.50 4,686.50

Fold the line items

Columns are period end dates